Synapse

← John A. Spertus

Papers by John A. Spertus

Page 5 · newest first

  1. Health status outcomes after spontaneous coronary artery dissection and comparison with other acute myocardial infarction: The VIRGO experiencePLoS ONE · 2022
  2. The association of improvement in left ventricular ejection fraction with outcomes in patients with heart failure with reduced ejection fraction: data from CHAMP‐HFEuropean Journal of Heart Failure · 2022
  3. Defining changes in physical limitation from the patient perspective: insights from the VITALITY‐HFpEF randomized trialEuropean Journal of Heart Failure · 2022
  4. Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIACirculation · 2022
  5. The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trialNature Medicine · 2022
  6. The shifting care and outcomes for patients with endangered limbs – Critical limb ischemia (SCOPE-CLI) registry overview of study design and rationaleIJC Heart & Vasculature · 2022
  7. Enhanced external counterpulsation for management of symptoms associated with long COVIDAmerican Heart Journal Plus Cardiology Research and Practice · 2022
  8. Data-Driven Individualized Surgical Decision-makingJAMA Surgery · 2021
  9. Identifying Patients at Increased Risk for Poor Outcomes from Heart Failure with Reduced Ejection Fraction: The PROMPT-HF Risk ModelESC Heart Failure · 2021
  10. Role of Frailty in Identifying Benefit From Transcatheter Versus Surgical Aortic Valve ReplacementCirculation Cardiovascular Quality and Outcomes · 2021
  11. Patient-reported vs. physician-estimated symptoms before and after transcatheter aortic valve replacementEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2021
  12. Development and Evaluation of an Audit and Feedback Process for Prevention of Acute Kidney Injury During Coronary Angiography and InterventionCJC Open · 2021
  13. Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure RegistryCirculation Heart Failure · 2021
  14. Performance Metrics for the Comparative Analysis of Clinical Risk Prediction Models Employing Machine LearningCirculation Cardiovascular Quality and Outcomes · 2021
  15. Risk Adjustment Model for Preserved Health Status in Patients With Heart Failure and Reduced Ejection Fraction: The CHAMP-HF RegistryCirculation Cardiovascular Quality and Outcomes · 2021
  16. Relative Prognostic Significance of Positron Emission Tomography Myocardial Perfusion Imaging Markers in CardiomyopathyCirculation Cardiovascular Imaging · 2021
  17. Identification of Frailty Using a Claims‐Based Frailty Index in the CoreValve Studies: Findings from the EXTEND‐FRAILTY StudyJournal of the American Heart Association · 2021
  18. Development and validation of a predictive model for bleeding after peripheral vascular intervention: A report from the National Cardiovascular Data Registry Peripheral Vascular Interventions RegistryCatheterization and Cardiovascular Interventions · 2021
  19. Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency DepartmentCirculation Cardiovascular Quality and Outcomes · 2021
  20. Baseline and Postprocedural Health Status Outcomes in Contemporary Patients With Atrial Fibrillation Who Underwent Catheter Ablation: A Report from the Japanese Outpatient RegistryJournal of the American Heart Association · 2021
  21. Association of sleep apnea with outcomes in peripheral artery disease: Insights from the PORTRAIT studyPLoS ONE · 2021
  22. Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia SeverityCirculation · 2021
  23. Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart FailureCirculation Heart Failure · 2021
  24. Personalizing the decision of dabigatran versus warfarin in atrial fibrillation: A secondary analysis of the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) trialPLoS ONE · 2021
  25. Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trialsHealth and Quality of Life Outcomes · 2021
  26. Natural History of Patients With Ischemia and No Obstructive Coronary Artery DiseaseCirculation · 2021
  27. Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection FractionJAMA Cardiology · 2021
  28. Factors indicating intention to vaccinate with a COVID-19 vaccine among older U.S. adultsPLoS ONE · 2021
  29. 2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference ReportCirculation · 2021
  30. Quality of Life in Patients With Heart Failure With Recovered Ejection FractionJAMA Cardiology · 2021
  31. Clinical and Economic Burden of Obstructive Hypertrophic Cardiomyopathy in the United StatesJournal of the American College of Cardiology · 2021
  32. Establishing Thresholds for Minimal Clinically Important Differences for the Peripheral Artery Disease QuestionnaireCirculation Cardiovascular Quality and Outcomes · 2021
  33. Association Between Sacubitril/Valsartan Initiation and Real-World Health Status Trajectories Over 18 Months in Heart Failure with Reduced Ejection FractionESC Heart Failure · 2021
  34. Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection FractionJAMA Cardiology · 2021
  35. Use of Machine Learning Models to Predict Death After Acute Myocardial InfarctionJAMA Cardiology · 2021
  36. Novel Trial Design: CHIEF-HFCirculation Heart Failure · 2021
  37. Treatment decisions for patients with peripheral artery disease and symptoms of claudication: Development process and alpha testing of the SHOW-ME PAD decision aidVascular Medicine · 2021
  38. Practical Application of Patient-Reported Health Status Measures for Transcatheter Valve TherapiesCirculation Cardiovascular Quality and Outcomes · 2021
  39. Predicting the EQ-5D utilities from the Kansas City Cardiomyopathy Questionnaire in patients with heart failureEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2021
  40. Sex differences in mortality and 90-day readmission rates after transcatheter aortic valve replacement: a nationwide analysis from the USAEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2021
  41. Interpretation of the Seattle Angina Questionnaire as an Outcome Measure in Clinical Trials and Clinical CareJAMA Cardiology · 2021
  42. Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortalityENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2021
  43. Quality of life in EMPEROR-Reduced: emphasizing what is important to patients while identifying strategies to support more patient-centred careEuropean Heart Journal · 2021
  44. Using Patient-Reported Outcomes to Assess Healthcare Quality: Toward Better Measurement of Patient-Centered Care in Cardiovascular DiseaseMethodist DeBakey Cardiovascular Journal · 2021
  45. Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United StatesJournal of Medical Economics · 2021
  46. Assessing health-related quality of life among patients with peripheral artery disease: A review of the literature and focus on patient-reported outcome measuresVascular Medicine · 2020
  47. Site-Level Variability in 30-Day Patient Outcomes After Transcatheter Mitral Valve Repair in the United StatesCirculation Cardiovascular Quality and Outcomes · 2020
  48. Intensity of Guideline-Directed Medical Therapy for Coronary Heart Disease and Ischemic Heart Failure OutcomesThe American Journal of Medicine · 2020
  49. Association of Diabetes Mellitus With Health Status Outcomes in Patients With Peripheral Artery Disease: Insights From the PORTRAIT RegistryJournal of the American Heart Association · 2020
  50. Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical CareJournal of the American College of Cardiology · 2020